Patient Information Leaflets (PILs)

Search information
Show items

These Patient Information Leaflets (PILs) are specially written by the British Association of Dermatologists (BAD).

The BAD has been awarded The Information Standard certification for the process it employs to develop information products aimed at the general public, which include PILs, Sun Awareness Campaign materials, and other information products.

The BAD shall hold responsibility for the accuracy of the information published, and neither the scheme operator nor the scheme owner shall have any responsibility for costs, losses, or direct or indirect damages or costs arising from inaccuracy of information or omissions in information published on the website on behalf of the BAD.

Displaying item Methotrexate

Methotrexate is known as a disease-modifying drug. It slows the production of new cells by the body’s immune system (the body's own defence system) and hence reduces inflammation whilst at the same time suppresses the activity of the immune system. It was first used to treat certain types of cancer, and was then found to also be an effective treatment for skin and joint diseases when used at lower doses.

Back to top